VERAXA Biotech reports in vitro data for its BiTAC-ADC platform
Go back to VERAXA Biotech reports in vitro data for its BiTAC-ADC platform| (NASDAQ: VRXA) | Delayed: 2.04 +0.31 (17.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.73 | 52 Week High | $ | |||
| Open | $1.77 | 52 Week Low | $ | |||
| Day High | $2.42 | P/E | N/A | |||
| Day Low | $1.77 | EPS | $ | |||
| Volume | 5,055,430 | |||||

